Fractyl Health Reports Positive Randomized Data from REMAIN-1 Midpoint Cohort Demonstrating Durable Weight Maintenance One Year After GLP-1 Discontinuation

Data ReadoutpositivePositive

AI Analysis

Summary

Fractyl Health announced positive midpoint data from the REMAIN-1 randomized trial showing durable weight maintenance one year after GLP-1 discontinuation. The results suggest sustained weight loss benefits following discontinuation of the GLP-1 agonist treatment.

Clinical Trial Data

Primary Endpoint

Met

Outcome Details

Durable weight maintenance one year after GLP-1 discontinuation demonstrated in REMAIN-1 midpoint cohort

Importance:6/10

Sentiment:

0.70

GLP-1weight lossclinical trialrandomized studyweight maintenance

Related Companies

$GUTS

Read the original article

Published by yahoo_finance on July 15, 2026 10:00 AM

Read Original